Refine by
Clinical Development Services Available In Iran
73 services found
Manufactured by:Elpiscience based inShanghai, CHINA
Elpiscience has assembled a global clinical team with a broad range of expertise from designing and leading first-in-human studies to executing large-scale global registration ...
Manufactured by:SOFIE based inDulles, VIRGINIA (USA)
Staying true to our vision to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics, SOFIE has acquired global rights for the diagnostic and companion diagnostic use of the FAPI family of compounds from University of Heidelberg, the team that invented PSMA-617 (Novartis). The FAPI family of compounds have demonstrated promising theranostic ...
by:Verana Health based inSan Francisco, CAMBODIA
Verana Health’s exclusive real-world data network and clinically true Qdata™ can help accelerate clinical trials in ophthalmology, urology, and neurology—from study startup through recruitment. From protocol development and clinical trial design to site selection and identifying potential participants*, we help ...
by:Novadiscovery based inLyon, FRANCE
Explore various regimens (dose, number of administrations per day, time between administrations, duration of treatment). Identify subgroups of optimal responders / theranostic biomarkers. Leverage real-world data to inform clinical trial ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
Pluristem’s goal is to provide patients, physicians and healthcare systems around the globe with standardized, easy to use and highly effective PLX cell products that need no genetic or tissue matching prior to administration. We are active with many respectful regulatory agencies worldwide to advance our clinical programs towards marketing. Part of our ...
Manufactured by:JMS Co.Ltd. based inHiroshima City, JAPAN
We aim for technological development to respond to the needs of next generation, and focus on clinical research and development in three main fields: Safety Infusion / Enteral Nutrition, Cardiovascular Therapy, and Hemodialysis / Peritoneal Dialysis. Also, we promote research in new areas such as Medical Information Technology, Regenerative ...
Manufactured by:Bio-Me based inOslo, NORWAY
PMP™ technology – Bridging the gap between clinical research and clinical practice by translating knowledge into actionable information. Microbiome Analysis Services for Pharma and Drug Developers. Bio-Me’s Precision Microbiome Profiling (PMP™) technology, based on qPCR, is perfectly positioned to support drug ...
by:Lifecore Biomedical, Inc. based inChaska,, MINNESOTA (USA)
Depending upon the requirements of the drug product, a variety of filling conditions can be tested and equipment ...
by:Lifecore Biomedical, Inc. based inChaska,, MINNESOTA (USA)
Lifecore’s engineering staff works with our formulation and development scientists to transfer or develop a robust process based on customer requirements and good engineering ...
by:Lifecore Biomedical, Inc. based inChaska,, MINNESOTA (USA)
Lifecore has decades of experience, using its proprietary filtration system, filter sterilizing very high viscosity solutions (>100,000 cps sodium hyaluronate solutions) while conforming to industry standards for filter ...
by:Lifecore Biomedical, Inc. based inChaska,, MINNESOTA (USA)
Drug product formulation development starts with an understanding of the drug substance. Our experts work with you to define and understand the anticipated use, desired performance criteria, characteristics of the drug product, distribution, storage, and ...
by:Latham BioPharm Group based inElkridge, MARYLAND (USA)
Moving products into clinical development is a key milestone that not only creates organizational value, but, more importantly, advances them closer towards commercialization, where they can serve the patients who need them the most. Once in the clinic, progressing through clinical trials is a complex endeavor that requires ...
by:International Drug Development Institute (IDDI) based inLouvain-la-Neuve, BELGIUM
Aiming at optimizing your clinical development strategy, our expert consultants develop the innovative strategies and capabilities needed to launch products with the greatest potential for commercial success and improved patient outcomes. ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
Femoral neck fracture is the most common form of hip fracture with annual treatment costs in the U.S. estimated to be between $10 to $15 billion, and are expected to rise due to the aging population, with mortality rates of up to 36%. *click for further information about Muscle injury due to total hip ...
Manufactured by:Destiny Pharma plc based inBrighton, UNITED KINGDOM
The company is focused on the clinical development and commercial exploitation through partnering of its highly innovative anti-infective portfolio and has an open door policy to discussing potential business relationships. These range from partnering and licensing through to investment and non-dilutive funding as well as risk sharing and joint ventures with ...
Distributed by:Avicanna Inc. based inToronto, ONTARIO (CANADA)
Advanced scientific platform for drug delivery, pre-clinical and clinical development. Team of 10+ scientists, deploying optimized proprietary methodologies in extraction, formulation development, analytical testing, pre-clinical models, and clinical development. Comprehensive IP ...
Manufactured by:Jubilant Therapeutics Inc. based inBedminster, NEW JERSEY (USA)
Jubilant Therapeutics is open for partnering or strategic. collaborations with biotech, pharma, academia, research labs for: Accelerating clinical development and market launch of our ongoing programs. Discovery/development of new programs in synergistic areas. Conducting research with our drug candidates either as monotherapy or in combination ...
Manufactured by:Rocket Pharmaceuticals, Inc. based inCranbury, NEW JERSEY (USA)
Rocket’s Research and Discovery group in the Cranbury, New Jersey facility utilizes approximately 20,000 square feet of state-of-the-art laboratories for designing, optimizing and advancing candidate therapeutics to clinical stage ...
Manufactured by:Atriva Therapeutics GmbH based inTübingen, GERMANY
The company’s lead drug candidate is the MEK inhibitor zapnometinib. The small molecule, which can be administered orally (tablet), is under advanced clinical development in two severe respiratory viral diseases: COVID-19 and influenza, two disease areas with urgent need for effective ...
by:Eurofins bioskin ( formely Bioskin GmbH) based inHamburg, GERMANY
The regulatory pathway for dermatological products, in particular topically applied products, differs from those for other therapeutic indications and dosage forms. Various options of proof-of-concept designs will help you move your development programs into the best direction. Early development of proper strategies shortens timelines and reduces costs. ...